<unk> , sold under the brand name Carbaglu among others, is used for the treatment of hyperammonaemia.<unk>  is a carbamoyl phosphate synthetase 1 (CPS 1) activator. The most common adverse effects include vomiting, abdominal pain, pyrexia (fever), and tonsillitis, anemia, diarrhea, ear infection, other infections, nasopharyngitis, decreased hemoglobin levels, and headache. It was approved for medical use in the United States in March 2010.<unk>  is an orphan drug.
Carglumic acid
Ioxaglic acid
Cimetidine
Sulforaphane
Sucralfate
Azacitidine
Dexlansoprazole
Rabeprazole